Screening According to WHO Global Burden of Disease it was estimated that the worldwide burden of diabetes in adults to be around 173 million in the year 2002. Diabetes screening tests are cost saving and effective as they allow to detect an early development of diabetes and prevent macrovascular and microvascular (retinopathy, neuropathy, nephropathy) complications. Individuals with undiagnosed type 2 diabetes (T2DM) are also at significantly higher risk for stroke, coronary heart disease, and peripheral